The UVM Medical Center is participating in a study on a potential new Lyme disease vaccine. But while people are excited about the possibility of preventing the disease, not everyone is on board just yet.
The FDA earlier this month approved what experts describe as a game changer and ray of hope for women’s health -- the first-ever pill for treating postpartum depression, and manufacturers say zuranolone could be commercially available as soon as October.
A new partnership between Vermont hospitals could be a lifesaver for babies in need of critical care. Our Jessica Tara reports on the technology connecting rural doctors with specialists at the UVM Medical Center.
Vermont is typically known for its clean air, but wildfires burning miles away in Canada have fouled the air this summer across the Green Mountain State. Alexandra Montgomery reports on what’s being done to track air quality.
Weekly weight loss injections like Ozempic and Wegovy have taken the country by storm thanks to trends on social and mainstream media. Now, the pharmaceutical company behind the medications is sounding the alarm on providers for prescribing the drugs irresponsibly.
Each state in the U.S. has a committee that decides how many conditions a newborn is tested for in the first day or two of life. Alexandra Montgomery reports on why Vermont doesn’t get the results for as many conditions as other states.
Rutland Regional Medical Center was the only hospital in Vermont that didn’t offer midwifery care. That is, until the Rutland Women’s Healthcare and the Women’s and Children’s Unit and Birthing Center brought Sarah Barton on board last month.